title: Managing disability benefits as part of treatment for persons with severe mental illness and comorbid drug/alcohol disorders. A comparative study of payee and non-payee participants.
abstract: The objective of this pilot study is to describe the use of a Social Security representative payee program as a clinical intervention integrated into long-term, dual-disorder treatment of severely mentally ill outpatients with comorbid drug/alcohol disorders. Compared with non-payees, patients selected to be payee participants were more likely to be male, have a diagnosis of schizophrenia, have a history of high inpatient utilization, and have higher current ratings of psychiatric symptoms, substance use, and functional disability. Despite these higher severity ratings, which usually predict poor outpatient compliance and higher rate of adverse outcomes, the payee participants attended about twice the number of outpatient service sessions as non-payees and were no more likely to be currently homeless, hospitalized, or incarcerated. The payee intervention is described, and ethical and research issues are discussed.
authors.affiliation: University of Washington School of Medicine, Seattle, USA.
authors.forename: R K
authors.initials: RK
authors.lastname: Ries
authors.forename: K A
authors.initials: KA
authors.lastname: Comtois
mesh_terms: D000066:Accounting; D000328:Adult; D000437:Alcoholism / Q000191:economics / Q000523:psychology / Q000534:rehabilitation*; D002017:Budgets; D019090:Case Management; D015897:Comorbidity; D017831:Diagnosis, Dual (Psychiatry); D004185:Disability Evaluation; D005260:Female; D006801:Humans; D013287:Illicit Drugs; D008297:Male; D008875:Middle Aged; D010043:Outcome and Process Assessment, Health Care; D010349:Patient Compliance / Q000523:psychology; D011619:Psychotropic Drugs; D012559:Schizophrenia / Q000191:economics / Q000534:rehabilitation*; D012565:Schizophrenic Psychology; D012943:Social Security / Q000191:economics*; D012949:Social Work, Psychiatric; D019966:Substance-Related Disorders / Q000191:economics / Q000523:psychology / Q000534:rehabilitation*
chemical_list: D013287:Illicit Drugs; D011619:Psychotropic Drugs